Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.

Schloer S, Brunotte L, Mecate-Zambrano A, Zheng S, Tang J, Ludwig S, Rescher U

Research article (journal) | Peer reviewed

Details about the publication

Journal: British Journal of Pharmacology

Volume: doi: 10.1111/bph.15418

Status: Published

Release year: 2021

Language in which the publication is written: English

Institute of Medical Biochemistry